Quince Therapeutics, Inc. (QNCX) › Total AssetsQuince Therapeutics, Inc. (QNCX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2018: $72.88M2019: $124.37M2020: $189.47M2021: $133.23M2022: $103.91M2023: $167.90M2024: $114.48M2025: $93.52M$93.52M2018Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$93.52M-18.3%2024$114.48M-31.8%2023$167.90M+61.6%2022$103.91M-22.0%2021$133.23M-29.7%2020$189.47M+52.3%2019$124.37M+70.7%2018$72.88M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share